Akter, A., & Alam, M. (2022). Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis. Brac University.
Citação do estilo Chicago (17ª ed.)Akter, Anika, e Marzia Alam. Pharmacokinetics, Safety, Efficacy and Immunogenicity of Adalimumab Biosimilar ABP-501in Rheumatoid Arthritis and Plaque Psoriasis. Brac University, 2022.
Citação MLA (8ª ed.)Akter, Anika, e Marzia Alam. Pharmacokinetics, Safety, Efficacy and Immunogenicity of Adalimumab Biosimilar ABP-501in Rheumatoid Arthritis and Plaque Psoriasis. Brac University, 2022.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.